These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39125513)

  • 21. Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?
    Feld J; Ye JY; Chandran V; Inman RD; Haroon N; Cook R; Gladman DD
    Rheumatology (Oxford); 2020 Jun; 59(6):1340-1346. PubMed ID: 31593590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.
    Gladman DD; Mease PJ; Bird P; Soriano ER; Chakravarty SD; Shawi M; Xu S; Quinn ST; Gong C; Leibowitz E; Poddubnyy D; Tam LS; Helliwell PS; Kavanaugh A; Deodhar A; Østergaard M; Baraliakos X
    Trials; 2022 Sep; 23(1):743. PubMed ID: 36064592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Back pain in psoriatic arthritis: defining prevalence, characteristics and performance of inflammatory back pain criteria in psoriatic arthritis.
    Yap KS; Ye JY; Li S; Gladman DD; Chandran V
    Ann Rheum Dis; 2018 Nov; 77(11):1573-1577. PubMed ID: 30077991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life.
    Aydin SZ; Kucuksahin O; Kilic L; Dogru A; Bayindir O; Ozisler C; Omma A; Tarhan EF; Erden A; Kimyon G; Can M; Dalkilic E; Yavuz S; Ureyen SB; Gunal EK; Alhussain FA; Akyol L; Balkarli A; Yilmaz S; Cinar M; Aydin MT; Solmaz D; Mercan R; Erten S; Kalyoncu U
    Clin Rheumatol; 2018 Dec; 37(12):3443-3448. PubMed ID: 29948352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Clinical Diagnosis of Axial Psoriatic Arthritis (PsA) or Elevated Patient-reported Spine Pain in CorEvitas' PsA/Spondyloarthritis Registry.
    Ogdie A; Blachley T; Lakin PR; Dube B; McLean RR; Hur P; Mease PJ
    J Rheumatol; 2022 Mar; 49(3):281-290. PubMed ID: 34853090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Definition and Measurement of Axial Psoriatic Arthritis.
    Lubrano E; Parsons WJ; Marchesoni A; Olivieri I; D'Angelo S; Cauli A; Caso F; Costa L; Scarpa R; Brunese L
    J Rheumatol Suppl; 2015 Nov; 93():40-2. PubMed ID: 26523055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treat-to-target in real-life psoriatic arthritis patients: achieving minimal disease activity with bDMARDs/tsDMARDs and potential barriers.
    Ortolan A; Lorenzin M; Cozzi G; Scagnellato L; Favero M; Striani G; Vio S; Scapin V; De Conti G; Doria A; Ramonda R
    Semin Arthritis Rheum; 2023 Oct; 62():152237. PubMed ID: 37453183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BASDAI versus ASDAS in evaluating axial involvement in patients with psoriatic arthritis: a pooled analysis of two phase 3 studies.
    Baraliakos X; Gladman DD; Chakravarty SD; Gong C; Shawi M; Rampakakis E; Kishimoto M; Soriano ER; Mease PJ
    Rheumatol Adv Pract; 2024; 8(2):rkae058. PubMed ID: 38765190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is Axial Psoriatic Arthritis the Same as Ankylosing Spondylitis With Psoriasis: A Debate.
    Coates LC; Deodhar A
    J Rheumatol; 2023 Nov; 50(Suppl 2):14-17. PubMed ID: 37419625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axial involvement in psoriatic arthritis: An update for rheumatologists.
    Poddubnyy D; Jadon DR; Van den Bosch F; Mease PJ; Gladman DD
    Semin Arthritis Rheum; 2021 Aug; 51(4):880-887. PubMed ID: 34198146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
    Burmester GR; Stigler J; Rubbert-Roth A; Tanaka Y; Azevedo VF; Coombs D; Lagunes I; Lippe R; Wung P; Gensler LS
    Rheumatol Ther; 2024 Jun; 11(3):737-753. PubMed ID: 38683479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria.
    Ficco HM; Citera G; Cocco JA
    Clin Rheumatol; 2014; 33(10):1489-93. PubMed ID: 24803232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Updated guidelines for the management of axial disease in psoriatic arthritis.
    Nash P; Lubrano E; Cauli A; Taylor WJ; Olivieri I; Gladman DD
    J Rheumatol; 2014 Nov; 41(11):2286-9. PubMed ID: 25362712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients.
    Luchetti Gentiloni MM; Paci V; Cimaroli I; Agostinelli A; Giannoni M; Campanati A; Diotallevi F; Carotti M; Sessa F; Sordillo R; Macchini C; Fiorini F; Massaccesi L; Ciferri M; Gigli M; Marconi V; Perini L; Marani A; Giovagnoni A; Polonara G; Offidani AM; Benfaremo D; Proft F; Poddubnyy D; Moroncini G
    Rheumatology (Oxford); 2024 Aug; 63(8):2152-2161. PubMed ID: 37878802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis.
    Chandran V; Tolusso DC; Cook RJ; Gladman DD
    J Rheumatol; 2010 Apr; 37(4):809-15. PubMed ID: 20231209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of TNF-α inhibition
    Elliott A; Wright G; Pendleton A; Rooney M
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X231179524. PubMed ID: 38024204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic Treatment Strategies in Psoriatic Arthritis.
    Ayan G; Ribeiro A; Macit B; Proft F
    Clin Ther; 2023 Sep; 45(9):826-840. PubMed ID: 37455227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability of radiographic scoring methods in axial psoriatic arthritis.
    Biagioni BJ; Gladman DD; Cook RJ; Eder L; Wakhlu A; Shen H; Chandran V
    Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1417-22. PubMed ID: 24515627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Saudi consensus recommendations for the management of psoriatic arthritis (2023).
    Al-Homood IA; Al Ghanim N; Fatani MIA; Hussein AH; Alolaiwi AM; Abualiat A; Alqurtas E; Alomari BAA; Khardaly AM; Alenzi KAO; Albarakati RG; Almudaiheem HY; Al-Jedai A; Eshmawi MTY
    Clin Rheumatol; 2024 Mar; 43(3):879-894. PubMed ID: 38217738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Medical care situation of patients with ankylosing spondylitis and psoriatic arthritis in Germany : Medical care situation of patients with spondyloarthritis (SpA): ankylosing spondylitis (AS) and psoriatic arthritis (PsA) from the perspective of rheumatologists in private practice and hospitals in Germany-Results of the research project "SpA Loop-Life of Outpatients"].
    Braun J; Schwarting A; Hammel L; Legeler C; Wimmer P; Färber L; Behrens F
    Z Rheumatol; 2019 May; 78(4):372-381. PubMed ID: 30874934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.